The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.40
Bid: 29.40
Ask: 31.40
Change: 0.00 (0.00%)
Spread: 2.00 (6.803%)
Open: 30.40
High: 30.40
Low: 30.40
Prev. Close: 30.40
MIG5 Live PriceLast checked at -
Maven Income and Growth VCT 5 is an Investment Trust

To invest in a diversified portfolio of later-stage UK private companies to provide long-term capital appreciation and generate maintainable levels of income for shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

17 Apr 2014 15:57

RNS Number : 1207F
Maven Income and Growth VCT 5 PLC
17 April 2014
 

 

Maven Income and Growth VCT 5 PLC (the Company)

 

Interim Management Statement - quarter ended 28 February 2014

 

This Interim Management Statement, for the quarter ended 28 February 2014, is provided in accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority and also includes relevant information in respect of the period from 1 March 2014 to the date of issue. This Statement has been prepared solely to provide additional information in order to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by Shareholders, or any other party, for any other purpose.

 

1.

Financial highlights

 

· Net Asset Value (NAV)1 of 40.30p per share at 28 February 2014, compared to 37.09p per share at 30 November 2013;

· NAV total return2 of 65.60p at 28 February 2014, compared to 62.39p at 30 November 2013; and

· Final dividend of 1.35p per share in respect of the year ended 30 November 2013, proposed for payment on 30 May 2014.

 

1The NAV is unaudited and reflects the closing bid price of quoted securities at 28 February 2014. Unlisted companies are normally valued on a six-monthly basis and the NAV incorporates the Directors' valuation of unlisted investments as at 30 November 2013, adjusted for subsequent events where appropriate.

2NAV total return is the sum of NAV per share and dividends paid per share since launch.

 

2.

Investments and disposals

 

During the quarter ended 28 February 2014: a total of £1,348,175 was invested in six private companies, five of these companies were new investments and one was a follow-on investment; aggregate proceeds of £1,763,526 were realised from the disposal of nine AIM quoted investments against a total cost of £1,860,797; and a net £3,196,700 was invested in short-dated UK Government Securities. A total of £291,475 was realised from the disposal of unlisted equities and loan stock.

 

3.

Recent developments

 

Between 1 March 2014 and the date of this Statement: £724,429 was invested in four unlisted companies, two of these companies were new investments and two were follow-on investments; the disposal of shares in eight AIM quoted investments realised aggregate proceeds of £874,221 against cost of £471,611; also the disposal of shares in one private company realised proceeds of £368,000 against a cost of £400,000 and the sale of UK Government Securities realised £3,000,000 of proceeds against £2,998,020 of cost.

 

 

4.

Offer for subscription

 

Up to and including 5 April 2014, the Company had received valid applications to the value of £3.07 million pursuant to its Offer for Subscription (the Offer), which opened on 24 October 2013. All valid applications in respect of the 2013/14 tax year, representing the sum of £2.77 million, have been accepted in full. Pursuant to the Offer, and subsequent to an initial allotment of 4,346,689 shares on 3 February 2014, the Company issued and allotted a further 2,310,321 Ordinary Shares of 10 pence each on 5 April 2014. The Offer Price at which all of these shares were issued and allotted was 41.58p per Ordinary Share. As a result of these allotments the number of Ordinary Shares now in issue is 67,512,435. It is intended that a further allotment, in respect of the 2014/15 tax year, will take place by no later than 30 April 2014 and will, in part, utilise the over-allotment facility set out in the Prospectus for the Offer.

 

Other than as described above and changes in the value of investments quoted on regulated markets, the Board is not aware of any events during the period from 1 December 2013 to 28 February 2014, or in the period from 1 March 2014 to the date of this announcement, which would have had a material impact on the financial position of the Company.

 

 

 

Issued on behalf of the Board

 

Maven Capital Partners UK LLP

Secretary

 

17 April 2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSZDLFFZZFEBBE
Date   Source Headline
3rd May 20249:28 amRNSIssue of Equity
1st May 202410:10 amRNSIssue of Equity
26th Apr 20242:44 pmRNSUnaudited NAV - Dividend Investment Scheme
23rd Apr 20242:27 pmRNSResult of AGM
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:49 pmRNSIssue of Equity
27th Mar 202410:31 amRNSIssue of Equity
22nd Mar 20244:25 pmRNSStatement re Offer for Subscription
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
20th Mar 20243:48 pmRNSUnaudited Net Asset Value
8th Mar 20242:57 pmRNSAnnual Financial Report
15th Feb 20244:45 pmRNSTransaction in Own Shares
8th Feb 202410:33 amRNSDirector/PDMR Shareholding
8th Feb 202410:12 amRNSIssue of Equity
7th Feb 20243:09 pmRNSDividend Declaration
19th Dec 20233:28 pmRNSIssue of Equity
18th Dec 20235:24 pmRNSUnaudited Net Asset Value
9th Nov 20233:51 pmRNSResult of General Meeting
20th Oct 20234:13 pmRNSTransaction in Own Shares
13th Oct 20234:56 pmRNSPublication of a Prospectus
4th Oct 20234:03 pmRNSNet Asset Value(s)
29th Aug 20239:15 amRNSDirectorate Change
24th Jul 202311:16 amRNSHalf-year Report
21st Jul 20234:43 pmRNSTransaction in Own Shares
21st Jul 20239:48 amRNSIssue of Equity
17th Jul 202310:57 amRNSNet Asset Value - Dividend Investment Scheme
11th Jul 20234:47 pmRNSNet Asset Value
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
14th Jun 202310:33 amRNSDividend Declaration
2nd Jun 20239:48 amRNSIssue of Equity
5th May 202310:23 amRNSIssue of Equity - Dividend Investment Scheme
27th Apr 20233:57 pmRNSTransaction in Own Shares
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
26th Apr 202311:39 amRNSNet Asset Value - Dividend Investment Scheme
25th Apr 20233:14 pmRNSNet Asset Value(s)
25th Apr 202312:50 pmRNSResult of AGM
5th Apr 202312:32 pmRNSIssue of Equity
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
23rd Mar 20235:18 pmRNSAnnual Financial Report
3rd Mar 20239:56 amRNSIssue of Equity
21st Feb 20234:44 pmRNSTransaction in Own Shares
8th Feb 202310:24 amRNSDirector/PDMR Shareholding
8th Feb 20239:48 amRNSIssue of Equity
1st Feb 20233:25 pmRNSUnaudited NAV and Proposed Final Dividend
9th Nov 20223:02 pmRNSResult of General Meeting
4th Nov 20223:25 pmRNSTransaction in Own Shares
26th Oct 20223:53 pmRNSTransaction in Own Shares
7th Oct 20224:28 pmRNSPublication of a Prospectus
4th Oct 20223:30 pmRNSChange of Auditor
4th Oct 20221:35 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.